Kazakhstan vs Pakistan: Prevalence rate of hypertension in men aged 30-79
Kazakhstan
40.9
in 2019
Pakistan
41.6
in 2019
Kazakhstan rank
63rd
Pakistan rank
59th
Prevalence rate of hypertension in men aged 30-79 over time
- Kazakhstan
- Pakistan
How they compare
Pakistan currently reports 41.6 against 40.9 in Kazakhstan, a difference of 0.7.
The two have swapped places 1 time across 30 shared years of data; in 1990 it was Kazakhstan ahead.
Kazakhstan ranks 63rd and Pakistan ranks 59th of 195 countries.
Across the 3 decades both report, Kazakhstan averaged higher in 1 and Pakistan in 2.
Head to head by decade
| Decade | Kazakhstan | Pakistan | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 37.73 | 37.37 | 0.36 | Kazakhstan |
| 2000s | 38.98 | 39.44 | 0.46 | Pakistan |
| 2010s | 40.56 | 41.01 | 0.45 | Pakistan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence rate of hypertension in men aged 30-79, Kazakhstan or Pakistan?
- Pakistan, at 41.6 against 40.9 in Kazakhstan as of 2019.
- What is the difference in prevalence rate of hypertension in men aged 30-79 between Kazakhstan and Pakistan?
- 0.7, with Pakistan ahead.
- How many years of comparable data are there for Kazakhstan and Pakistan?
- 30 years are reported by both, from 1990 to 2019.
- How do Kazakhstan and Pakistan rank globally for prevalence rate of hypertension in men aged 30-79?
- Kazakhstan ranks 63rd and Pakistan ranks 59th of 195 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Prevalence rate of hypertension in men aged 30-79. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated share of male population with hypertension, based on population representative surveys and statistical modeling. Hypertension is a risk factor for chronic complications, including cardiovascular disease, and premature death.